Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study.
Julsgaard M, Baumgart DC, Baunwall SMD, Hansen MM, Grosen A, Bibby BM, Uldbjerg N, Kjeldsen J, Sørensen HG, Larsen L, Wildt S, Weimers P, Haderslev KV, Vind I, Svenningsen L, Brynskov J, Lyhne S, Vestergaard T, Hvas CL, Kelsen J; NOVA Study Group.
Julsgaard M, et al. Among authors: kelsen j.
Aliment Pharmacol Ther. 2021 Nov;54(10):1320-1329. doi: 10.1111/apt.16593. Epub 2021 Sep 2.
Aliment Pharmacol Ther. 2021.
PMID: 34472644